These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12359643)

  • 1. Treatment, tuberculosis, and human leukocyte antigen.
    Bothamley GH
    Am J Respir Crit Care Med; 2002 Oct; 166(7):907-8. PubMed ID: 12359643
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinico-immunological variants of drug-induced toxic hepatitis in pulmonary tuberculosis patients].
    Frolov VM; Peresadin NA; Petrunia AM
    Probl Tuberk; 1993; (6):17-9. PubMed ID: 8290522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment.
    Sharma SK; Balamurugan A; Saha PK; Pandey RM; Mehra NK
    Am J Respir Crit Care Med; 2002 Oct; 166(7):916-9. PubMed ID: 12359646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of liver diseases in patients with pulmonary tuberculosis].
    El'kin AV; Ariél' BM; Nechaev VV
    Probl Tuberk; 1992; (7-8):15-8. PubMed ID: 1488430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M; Endo K; Noguchi T; Nakano M
    Iryo; 1966 Apr; 20(4):347-53. PubMed ID: 5974193
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Danger of liver damage in modern antitubercular treatment].
    Kozma D; Lapis K; Debreczeni L
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():479-81. PubMed ID: 6647279
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver function testing in African patients on treatment for tuberculosis.
    Davies PD
    East Afr Med J; 1985 Jul; 62(7):486-90. PubMed ID: 4076028
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis due to anti-tuberculous drugs.
    Aggarwal NP
    Indian J Chest Dis Allied Sci; 1992; 34(4):231-2. PubMed ID: 1302758
    [No Abstract]   [Full Text] [Related]  

  • 14. [The efficacy of treating patients with destructive pulmonary tuberculosis with liver involvement].
    Novozhylova IO
    Lik Sprava; 1998; (7):121-3. PubMed ID: 10050479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver damage from tuberculosis treatment].
    Keiner F
    Med Klin; 1981 Jun; 76(13):376-7. PubMed ID: 7254121
    [No Abstract]   [Full Text] [Related]  

  • 16. [Incidence and nature of adverse reactions to antitubercular drugs in children with primary intrathoracic tuberculosis].
    Kurmanova NK
    Probl Tuberk; 1988; (6):33-6. PubMed ID: 2974988
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a mathematic method of prognosis in adverse reactions to chemotherapy of tuberculosis].
    Kazakov KS; Kozarev MI
    Probl Tuberk; 1987; (2):43-5. PubMed ID: 3575279
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of Astragalus dasyanthus in lesions of the liver in patients with pulmonary tuberculosis].
    Skakun NP; Blikhar EI; Oleĭnik AN
    Vrach Delo; 1988 Jun; (6):51-4. PubMed ID: 3420913
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver function tests during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin & pyrazinamide.
    Swamy R; Acharyulu GS; Duraipandian M; Jawahar MS; Ramachandran R; Sarma GR
    Indian J Med Res; 1987 Nov; 86():549-57. PubMed ID: 3451899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.